ImmunoPrecise Antibodies Ltd.
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	4/30/2022	4/30/2023	4/30/2024	4/30/2026	4/30/2027	4/30/2028
Revenue % change YoY	$19.36M N/A	$20.66M 6.71%	$24.51M 18.64%	Avg: $36.28M Low: $36.28M High: $36.28M avg. 47.99%	Avg: $44.33M Low: $44.33M High: $44.33M avg. 22.19%	Avg: $54.21M Low: $54.21M High: $54.21M avg. 22.27%
Net Income % change YoY	$-16.70M N/A	$-26.56M -58.95%	$-27.17M -2.32%	Avg: $-3.97M Low: $-3.97M High: $-3.97M avg. 85.38%	Avg: $1.73M Low: $1.73M High: $1.73M avg. 143.74%	Avg: $8.44M Low: $8.44M High: $8.44M avg. 385.71%
EBITDA % change YoY	$-12.12M N/A	$-21.03M -73.54%	$-22.94M -9.08%	Avg: $-14.67M Low: $-14.67M High: $-14.67M avg. 36.05%	Avg: $-17.93M Low: $-17.93M High: $-17.93M avg. -22.19%	Avg: $-21.92M Low: $-21.92M High: $-21.92M avg. -22.27%
EPS % change YoY	-$0.85 N/A	-$1.07 -25.88%	-$1.06 0.93%	Avg: -$0.16 Low: -$0.16 High: -$0.16 avg. 84.94%	Avg: $0.07 Low: $0.07 High: $0.07 avg. 143.74%	Avg: $0.34 Low: $0.34 High: $0.34 avg. 385.71%
Operating Expenses % change YoY	$27.15M N/A	$39.78M 46.51%	$12.05M -69.70%	Avg: $30.18M Low: $30.18M High: $30.18M avg. 150.47%	Avg: $36.88M Low: $36.88M High: $36.88M avg. 22.19%	Avg: $45.10M Low: $45.10M High: $45.10M avg. 22.27%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 204.94% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is -3.97M, average is -3.97M and high is -3.97M.

Wall Street analysts forecast annual average revenue growth of 30.82% in 2026-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $36.28M, average is $36.28M and high is $36.28M.

Wall Street analysts forecast annual average earnings growth of 204.80% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.16, average is -$0.16 and high is $-0.15.